EGFR and central nervous system cancer: The presence of EGFR mutations significantly promotes the invasive capacity of glioma cells through the regulation of integrin [48,49], CAMs [50], urokinase-type plasminogen activator/receptor (uPA/uPAR) [51,52], MMPs [53,54] and microRNAs [55,56].